ArticleBJUI compass2025

Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancer.

Agnieszka Krzyzanowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.